“Convergence science has advanced across many fronts, from nanotechnology to regenerative tissue,” says Nobel Laureate Phil Sharp of MIT. “But the funding allocated for convergence research in biomedical science is small and needs to be expanded. In fact, there is no federal agency with the responsibility to fund convergence in biomedical research.”
AC Immune has entered into a second exclusive worldwide license agreement and research collaboration with Genentech,of the Roche Group, for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases. The agreement is valued at $400M.
New Cambridge Observer : to harness and allow sharing of exponentially-developing genetic data, the Broad Institute will launch “Genome Space,”–a co-operative Web based tool aimed at “frictionless” data transfer, later this week.
I was blown away when I heard about pill bottle caps that will tell you (or your doctor or your caretakers) if you’ve forgotten to take your meds…a kazoo that measures the chemistry of the air from your lungs…and a telephone that can assess whether you’re depressed–from the tones of your voice. Remote health monitoring gizmos are not for the future: they are now!
The MLSC, charged with distributing some $1B over a ten year period, invested $48.5 M in public dollars this year–its first full year of operation. The funds, in turn, have attracted nearly $359M in matching investments from companies, foundations, government, institutes and other private investors–an eight-fold return.